Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Department of Neurology, Columbia University, New York, NY, USA.
Impaired proteasome function is a potential mechanism for dopaminergic neuron degeneration. To model this molecular defect, we administered systemically the reversible lipophilic proteasome inhibitor, carbobenzoxy-L-isoleucyl-gamma-t-butyl-L-glutamyl-L-alanyl-L-leucinal (PSI), to rodents. In contrast to a previous report, this approach failed to cause any detectable behavioral or neuropathological abnormality in either rats or mice. Although theoretically appealing, this specific model of Parkinson's disease appears to exhibit poor reproducibility.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on